|
US4166452A
(en)
|
1976-05-03 |
1979-09-04 |
Generales Constantine D J Jr |
Apparatus for testing human responses to stimuli
|
|
US4804663A
(en)
|
1985-03-27 |
1989-02-14 |
Janssen Pharmaceutica N.V. |
3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
|
|
US5576195A
(en)
*
|
1985-11-01 |
1996-11-19 |
Xoma Corporation |
Vectors with pectate lyase signal sequence
|
|
US6893625B1
(en)
*
|
1986-10-27 |
2005-05-17 |
Royalty Pharma Finance Trust |
Chimeric antibody with specificity to human B cell surface antigen
|
|
EP0560410B1
(en)
|
1987-04-27 |
2002-10-02 |
Inverness Medical Switzerland GmbH |
A test device for performing specific binding assays
|
|
US5120643A
(en)
|
1987-07-13 |
1992-06-09 |
Abbott Laboratories |
Process for immunochromatography with colloidal particles
|
|
AU2684488A
(en)
|
1988-06-27 |
1990-01-04 |
Carter-Wallace, Inc. |
Test device and method for colored particle immunoassay
|
|
US5252496A
(en)
|
1989-12-18 |
1993-10-12 |
Princeton Biomeditech Corporation |
Carbon black immunochemical label
|
|
DE69232002T2
(de)
|
1991-06-07 |
2002-06-06 |
Johnson & Johnson Clinical Diagnostics, Inc. |
Immunoassays unter Verwendung von markierten Hapten-Analogen
|
|
FI941572L
(fi)
|
1991-10-07 |
1994-05-27 |
Oncologix Inc |
Anti-erbB-2-monoklonaalisten vasta-aineiden yhdistelmä ja käyttömenetelmä
|
|
TW268005B
(cg-RX-API-DMAC7.html)
|
1992-05-29 |
1996-01-11 |
Lilly Industries Ltd |
|
|
US6034078A
(en)
|
1992-05-29 |
2000-03-07 |
Eli Lilly And Company Limited |
Thienobenzodiazepine compounds
|
|
US5642870A
(en)
|
1992-08-05 |
1997-07-01 |
Sargis; Ike |
Switch stand
|
|
US5395933A
(en)
|
1992-08-07 |
1995-03-07 |
Eastman Kodak Company |
Carbamazepine hapten analogues
|
|
SK282231B6
(sk)
|
1993-11-19 |
2001-12-03 |
Janssen Pharmaceutica N. V. |
Farmaceutický prostriedok na liečenie psychotických porúch
|
|
EP0804580B1
(en)
|
1994-06-10 |
2008-10-08 |
Oklahoma Medical Research Foundation |
Calcium binding recombinant antibody against protein c
|
|
US5641870A
(en)
|
1995-04-20 |
1997-06-24 |
Genentech, Inc. |
Low pH hydrophobic interaction chromatography for antibody purification
|
|
US5761894A
(en)
|
1996-09-25 |
1998-06-09 |
Magic Circle Corporation |
Grass striping attachment for lawn mowers
|
|
US6139800A
(en)
|
1997-06-23 |
2000-10-31 |
Luminex Corporation |
Interlaced lasers for multiple fluorescence measurement
|
|
US6830731B1
(en)
|
1998-01-05 |
2004-12-14 |
Biosite, Inc. |
Immunoassay fluorometer
|
|
US6362371B1
(en)
|
1998-06-08 |
2002-03-26 |
Advanced Medicine, Inc. |
β2- adrenergic receptor agonists
|
|
US20030143233A1
(en)
|
1999-06-07 |
2003-07-31 |
Neorx Corporation |
Streptavidin expressed gene fusions and methods of use thereof
|
|
RU2181297C2
(ru)
*
|
2000-06-20 |
2002-04-20 |
Эпштейн Олег Ильич |
Способ лечения патологического синдрома и лекарственное средство
|
|
US7163681B2
(en)
|
2000-08-07 |
2007-01-16 |
Centocor, Inc. |
Anti-integrin antibodies, compositions, methods and uses
|
|
US6958156B2
(en)
|
2000-12-15 |
2005-10-25 |
Vyrex Corporation |
Isoflavone derivatives
|
|
JP4559081B2
(ja)
*
|
2002-01-25 |
2010-10-06 |
ジーツー セラピーズ リミテッド |
抗Ｃ５ａＲ抗体及びその使用
|
|
EP1333023B1
(en)
|
2002-01-31 |
2010-12-22 |
Randox Laboratories Ltd. |
Immunogens, antibodies and conjugates to ketamine and its metabolites
|
|
EP1476120B1
(en)
|
2002-02-21 |
2010-09-29 |
Duke University |
Treatment methods using anti-cd22 antibodies
|
|
AU2003217676B2
(en)
|
2002-02-22 |
2009-06-11 |
Takeda Pharmaceutical Company Limited |
Active agent delivery systems and methods for protecting and administering active agents
|
|
CA2479932A1
(en)
|
2002-03-28 |
2003-10-09 |
Eli Lilly And Company |
Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders
|
|
SE0201738D0
(sv)
|
2002-06-07 |
2002-06-07 |
Aamic Ab |
Micro-fluid structures
|
|
AU2003259256A1
(en)
|
2002-07-29 |
2004-02-16 |
Potomac Pharma, LLC. |
Antipsychotic combination therapies and compositions of an alpha-2 adrenergic receptor antagonist and an atypical antipsychotic neuroleptic
|
|
DK1546134T3
(da)
|
2002-08-05 |
2007-09-10 |
Lilly Co Eli |
Piperazinsubstituerede arylbenzodiazepiner
|
|
US7271252B2
(en)
|
2003-04-22 |
2007-09-18 |
Roche Diagnostics Operations, Inc. |
Reagents for detecting efavirenz
|
|
JP5416338B2
(ja)
|
2003-05-09 |
2014-02-12 |
デューク ユニバーシティ |
Ｃｄ２０特異的抗体およびその使用方法
|
|
HRP20121010T1
(hr)
|
2003-08-18 |
2013-01-31 |
H. Lundbeck A/S |
Trans-1(6-klor-3-fenilindan-1-il)-3,3-dimetilpiperazin
|
|
ES2335589T3
(es)
|
2003-09-23 |
2010-03-30 |
Fermion Oy |
Preparacion de quetiapina.
|
|
NZ593444A
(en)
|
2003-10-01 |
2012-12-21 |
Adolor Corp |
4-[(2-N,N-diethylaminocarbonyl)pyrid-5-yl]-spiro[1,2-dihydronaphthalene-2,4'-piperidine] and methods of its use
|
|
JP4836797B2
(ja)
*
|
2003-10-23 |
2011-12-14 |
大塚製薬株式会社 |
放出制御性無菌注射アリピプラゾール製剤および方法
|
|
EP1706743B1
(en)
*
|
2003-12-12 |
2009-11-18 |
Inverness Medical Switzerland GmbH |
Assay
|
|
GB0328892D0
(en)
*
|
2003-12-12 |
2004-01-14 |
Inverness Medical Switzerland |
Positive signal assay for analytes
|
|
SE0400662D0
(sv)
|
2004-03-24 |
2004-03-24 |
Aamic Ab |
Assay device and method
|
|
JP4943144B2
(ja)
|
2004-04-26 |
2012-05-30 |
松山 隆美 |
葉酸リセプターベータ（ＦＲ−β）に対する単クローン抗体を含有する治療薬
|
|
SE527036C2
(sv)
|
2004-06-02 |
2005-12-13 |
Aamic Ab |
Analysanordning med reglerat flöde och motsvarande förfarande
|
|
TW200616604A
(en)
|
2004-08-26 |
2006-06-01 |
Nicholas Piramal India Ltd |
Nitric oxide releasing prodrugs containing bio-cleavable linker
|
|
US20060235005A1
(en)
|
2005-04-14 |
2006-10-19 |
Oak Labs, Corp. |
Use of phosphodiesterase 5 (PDE5) inhibitors in the treatment of schizophrenia
|
|
BRPI0612972A2
(pt)
*
|
2005-04-22 |
2010-12-14 |
Genentech Inc |
mÉtodo para tratar doenÇa de alzheimer, mÉtodo para tratar demÊncia, artigo de fabricaÇço e usos de um anticorpo cd20
|
|
US20080214808A1
(en)
|
2005-04-25 |
2008-09-04 |
Thomas Frederik Ernestine Spittaels |
Preparation of Aseptic 3-[2-[4-((6-Fluoro-1,2-Benzisoxazol-3-Yl)-1-Piperidinyl]-6,7,8,9-Tetrahydro-9-Hydroxy-2-Methyl-4H-Pyrido[1,2-a]Pyrimidin-4-One Palmitate Ester
|
|
SE529254C2
(sv)
|
2005-06-17 |
2007-06-12 |
Aamic Ab |
Optiskt testsystem
|
|
SE528233C2
(sv)
|
2005-06-20 |
2006-09-26 |
Aamic Ab |
Metod och medel för att åstadkomma vätsketransport
|
|
SE529711C2
(sv)
|
2006-03-22 |
2007-11-06 |
Aamic Ab |
Fluorescensläsare
|
|
US8975374B2
(en)
*
|
2006-10-20 |
2015-03-10 |
Chugai Seiyaku Kabushiki Kaisha |
Pharmaceutical composition comprising anti-HB-EGF antibody as active ingredient
|
|
US20100061933A1
(en)
|
2006-10-20 |
2010-03-11 |
Naoki Kimura |
Pharmaceutical composition comprising anti-hb-egf antibody as active ingredient
|
|
WO2008047914A1
(fr)
*
|
2006-10-20 |
2008-04-24 |
Forerunner Pharma Research Co., Ltd. |
Agent anticancéreux comprenant un anticorps anti-hb-egf en tant qu'ingrédient actif
|
|
US8394790B2
(en)
|
2006-10-25 |
2013-03-12 |
Ramot At Tel-Aviv University Ltd. |
Psychotropic agents having glutamate NMDA activity
|
|
US20080138842A1
(en)
|
2006-12-11 |
2008-06-12 |
Hans Boehringer |
Indirect lateral flow sandwich assay
|
|
CA2672581A1
(en)
*
|
2006-12-14 |
2008-06-19 |
Forerunner Pharma Research Co., Ltd. |
Anti-claudin 3 monoclonal antibody and treatment and diagnosis of cancer using the same
|
|
ES2405364T3
(es)
|
2006-12-29 |
2013-05-30 |
Abbott Laboratories |
Ensayo diagnóstico para la detección de una molécula o fármaco en sangre entera
|
|
US8071767B2
(en)
|
2007-01-08 |
2011-12-06 |
Actavis Group Ptc Ehf |
Process for preparation of 9-hydroxy-3-(2-chloroethyl)-2-methyl-4H-pyrido[1,2-A]pyrimidin-4-one hydrochloride
|
|
CN101245065B
(zh)
|
2007-02-14 |
2010-05-19 |
江苏恩华药业股份有限公司 |
制备苯并异噁唑衍生物的方法及其中间体
|
|
MX2010003259A
(es)
|
2007-09-27 |
2010-04-12 |
Novartis Ag |
Ensayo de monitoreo de farmacos.
|
|
EA028427B1
(ru)
|
2008-07-21 |
2017-11-30 |
Пробиодруг Аг |
АНТИТЕЛО, СВЯЗЫВАЮЩЕЕСЯ С Aβ-ПЕПТИДАМИ ИЛИ ИХ ВАРИАНТАМИ, КОМПОЗИЦИЯ, СОДЕРЖАЩАЯ ЭТО АНТИТЕЛО, И ЕГО ПРИМЕНЕНИЕ
|
|
MX2011001384A
(es)
|
2008-08-06 |
2011-09-27 |
Gosforth Ct Holdings Pty Ltd |
Composiciones y metodos para tratar trastornos psiquiatricos.
|
|
WO2010033270A1
(en)
|
2008-09-17 |
2010-03-25 |
Auspex Pharmaceuticals, Inc. |
Dibenzothiazepine modulators of dopamine, alpha adrenergic, and serotonin receptors
|
|
AU2009305203B2
(en)
|
2008-10-14 |
2013-03-07 |
Entasis Therapeutics Limited |
Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections
|
|
CA2742074A1
(en)
|
2008-10-29 |
2010-08-26 |
Janssen Pharmaceutica Nv |
Methods of treating psychosis and schizophrenia based on polymorphisms in the erbb4 gene
|
|
EP2194048A1
(en)
|
2008-12-02 |
2010-06-09 |
Dirk Sartor |
Nitrate esters for the treatment of vascular and metabolic diseases
|
|
US8480333B2
(en)
|
2008-12-26 |
2013-07-09 |
Steven Edward DeMay |
Frame rail assemblies and interlocking frame rail systems
|
|
AU2010206376B2
(en)
|
2009-01-26 |
2012-10-18 |
Egalet Ltd. |
Controlled release formulations with continuous efficacy
|
|
CN103415534A
(zh)
|
2009-03-10 |
2013-11-27 |
贝勒研究院 |
靶向抗原呈递细胞的癌症疫苗
|
|
JP5732453B2
(ja)
|
2009-06-25 |
2015-06-10 |
アルカーメス ファーマ アイルランド リミテッド |
Ｎｈ酸性化合物のプロドラッグ
|
|
RU2562865C2
(ru)
*
|
2009-07-10 |
2015-09-10 |
Иннэйт Фарма |
Tlr3 связывающие агенты
|
|
PL2459220T3
(pl)
|
2009-07-31 |
2021-03-08 |
Ascendis Pharma A/S |
Biodegradowalne nierozpuszczalne w wodzie hydrożele na bazie poli(glikolu etylenowego)
|
|
AU2010285974A1
(en)
*
|
2009-08-17 |
2012-03-22 |
Forerunner Pharma Research Co., Ltd. |
Pharmaceutical composition comprising anti-HB-EGF antibody as active ingredient
|
|
WO2011042450A1
(en)
|
2009-10-06 |
2011-04-14 |
Ascendis Pharma As |
Carrier linked paliperidone prodrugs
|
|
EP2343296A1
(en)
|
2009-12-01 |
2011-07-13 |
Chemo Ibérica, S.A. |
A process for the purification of paliperidone
|
|
CN102781236B
(zh)
|
2009-12-31 |
2015-01-07 |
凯姆制药公司 |
喹硫平的氨基酸缀合物、其制备和使用方法
|
|
HUE042945T2
(hu)
|
2010-03-11 |
2019-07-29 |
Kempharm Inc |
Kvetiapin zsírsav-konjugátumai, eljárás ugyanannak elkészítésére és felhasználására
|
|
US8114621B2
(en)
|
2010-03-12 |
2012-02-14 |
Saladax Biomedical Inc. |
Lenalidomide and thalidomide immunoassays
|
|
US8088594B2
(en)
|
2010-03-16 |
2012-01-03 |
Saladax Biomedical Inc. |
Risperidone immunoassay
|
|
WO2011159537A2
(en)
|
2010-06-15 |
2011-12-22 |
The Regents Of The University Of California |
Method and device for analyte detection
|
|
US8530413B2
(en)
|
2010-06-21 |
2013-09-10 |
Sanofi |
Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
|
|
US8592427B2
(en)
|
2010-06-24 |
2013-11-26 |
Alkermes Pharma Ireland Limited |
Prodrugs of NH-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives
|
|
WO2012003418A2
(en)
|
2010-07-02 |
2012-01-05 |
The University Of North Carolina At Chapel Hill |
Functionally selective ligands of dopamine d2 receptors
|
|
US8623324B2
(en)
|
2010-07-21 |
2014-01-07 |
Aat Bioquest Inc. |
Luminescent dyes with a water-soluble intramolecular bridge and their biological conjugates
|
|
PH12013500333A1
(en)
*
|
2010-08-20 |
2013-04-22 |
Novartis Ag |
Antibodies for epidermal growth factor receptor 3 (her3)
|
|
US8790651B2
(en)
|
2011-07-21 |
2014-07-29 |
Zoetis Llc |
Interleukin-31 monoclonal antibody
|
|
HK1198629A1
(en)
|
2011-08-12 |
2015-05-22 |
Ascendis Pharma A/S |
High-loading water-soluble carrier-linked prodrugs
|
|
AU2012296950B2
(en)
|
2011-08-12 |
2016-09-22 |
Ascendis Pharma A/S |
Polymeric hyperbranched carrier-linked prodrugs
|
|
US8969337B2
(en)
|
2011-12-15 |
2015-03-03 |
Alkermes Pharma Ireland Limited |
Prodrugs of secondary amine compounds
|
|
KR20150042269A
(ko)
|
2012-08-16 |
2015-04-20 |
얀센 파마슈티카 엔.브이. |
N형 칼슘 채널 차단제로서의 치환된 피라졸
|
|
PL2888269T3
(pl)
|
2012-08-21 |
2019-06-28 |
Janssen Pharmaceutica Nv |
Hapteny olanzapiny
|
|
AU2013305907B2
(en)
|
2012-08-21 |
2018-01-18 |
Saladax Biomedical Inc. |
Antibodies to quetiapine and use thereof
|
|
ES2733963T3
(es)
|
2012-08-21 |
2019-12-03 |
Janssen Pharmaceutica Nv |
Anticuerpos contra haptenos de olanzapina y uso de los mismos
|
|
PL3321254T3
(pl)
|
2012-08-21 |
2021-01-11 |
Janssen Pharmaceutica Nv |
Hapteny arypiprazolu i ich zastosowanie w testach immunologicznych
|
|
EP3663316A1
(en)
|
2012-08-21 |
2020-06-10 |
Janssen Pharmaceutica NV |
Antibodies to aripiprazole and use thereof
|
|
PT3663317T
(pt)
|
2012-08-21 |
2023-01-23 |
Janssen Pharmaceutica Nv |
Anticorpos para haptenos de quetiapina e sua utilização
|
|
PT3415516T
(pt)
|
2012-08-21 |
2022-01-28 |
Janssen Pharmaceutica Nv |
Haptenos de risperidona e paliperidona
|
|
ES2739383T3
(es)
|
2012-08-21 |
2020-01-30 |
Janssen Pharmaceutica Nv |
Haptenos de paliperidona
|
|
JP6131415B2
(ja)
|
2012-08-21 |
2017-05-24 |
ヤンセン ファーマシューティカ エヌ．ベー． |
イムノアッセイに使用するためのクエチアピンのハプテン
|
|
JP2015529199A
(ja)
|
2012-08-21 |
2015-10-05 |
オルソ−クリニカル ダイアグノスティクス，インコーポレイティド |
パリペリドンハプテンに対する抗体及びその使用
|
|
CN108640996A
(zh)
*
|
2012-08-21 |
2018-10-12 |
詹森药业有限公司 |
帕潘立酮的抗体及其用途
|
|
US9494608B2
(en)
|
2012-08-21 |
2016-11-15 |
Janssen Pharmaceutica Nv |
Antibodies to olanzapine and use thereof
|
|
CN104736567B
(zh)
|
2012-08-21 |
2019-09-03 |
詹森药业有限公司 |
阿立哌唑半抗原的抗体及其用途
|
|
CA2882563C
(en)
*
|
2012-08-21 |
2022-11-29 |
Eric Hryhorenko |
Antibodies to risperidone haptens and use thereof
|
|
PL3462173T3
(pl)
|
2012-08-21 |
2021-08-16 |
Janssen Pharmaceutica Nv |
Przeciwciała przeciwko rysperydonowi i ich zastosowanie
|
|
US9453002B2
(en)
|
2013-08-16 |
2016-09-27 |
Janssen Pharmaceutica Nv |
Substituted imidazoles as N-type calcium channel blockers
|
|
EP3390449A1
(en)
|
2015-12-17 |
2018-10-24 |
Janssen Pharmaceutica N.V. |
Antibodies to risperidone and use thereof
|